Reported covered position: None
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Consolidated Appropriations Act, 2016
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 209/S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and National Institutes of Health funding HR 605/S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access
Ensuring Access to Clinical Trials Act of 2015
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2015 · fourth_quarter · Q4
HR 209/S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and National Institutes of Health funding HR 605/S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
HR 209/S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and National Institutes of Health funding HR 605/S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access
Medicare Home Infusion Site of Care Act of 2015
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 209/S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and National Institutes of Health funding HR 605/S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access
Ensuring Access to Clinical Trials Act of 2015
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 209/S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and National Institutes of Health funding HR 605/S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access
Medicare Home Infusion Site of Care Act of 2015
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
HR 209/S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and National Institutes of Health funding HR 605/S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access